7:45 a.m. - 8:30 a.m. |
Breakfast and Industry Symposium
Additional details to come.
|
8:45 a.m. - 10:00 a.m. |
President's Welcome & Dr. Sidney Wallace and Dr. Michael J. Wallace Distinguished Lecture
- President's Welcome, Muneeb Ahmed, MD, FSIR, Beth Israel Deaconess Medical Center/Harvard Medical School
- Program Chair's Program Overview, Vijay Ramalingam, MD, FSIR, Beth Israel Deaconess Medical Center/Harvard Medical School
- Dr. Sidney Wallace and Dr. Michael J. Wallace Distinguished Lecture, Prof. Thierry de Baere, MD, Gustave Roussy Cancer Center
|
10:30 a.m. - 11:30 a.m. |
State-of-the-Art HCC
Moderators: Laura Crocetti, MD, PhD, EBIR, University of Pisa; Parissa Tabrizian, MD, MSc, FACS, Mount Sinai Medical Center
- Standard of Care Systemic Therapies and Pivotal Trials, Adam Burgoyne, MD, PhD, UC San Diego
- Barcelona Update and BCLC Stage Migration Issues, David C. Madoff, MD, Yale School of Medicine
- 2024 Resection and Transplantation Updates, Parissa Tabrizian, MD, MSc, FACS, Mount Sinai Medical Center
- Current Status: Locoregional Primer, Laura Crocetti, MD, PhD, EBIR, University of Pisa
|
11:30 a.m. - 12:45 p.m. |
Expo Hall, Lunch and Industry Symposia
Additional details to come.
|
12:45 p.m. - 2:15 p.m. |
Lung Cancer and Lung Mets Tumor Board
Moderators: Robert Suh, MD, David Geffen School of Medicine at UCLA; Damian E. Dupuy, MD, FACR, Cape Cod Health Care
- Clinical Trials and Patient Selection in Lung Cancer Ablation: Where Does IR Stand? Alda Tam, MD, MD Anderson Cancer Center
- Ablation and SBRT in Lung Cancer: How Do We Decide? Florian J. Fintelmann, MD, Massachussetts General Hospital
- Screening and Treatment of Small Lesions, Damian E. Dupuy, MD, FACR, Cape Cod Health Care
- Techniques and Approaches to Complicated Lesions, Robert Short, MD, PhD, Dayton VAMC/WSU BSOM
- State-of-the-Art Endobronchial Techniques for Lung Cancer Staging and Treatment, Michael Pritchett, DO, MPH, FirstHealth of the Carolinas
- Lung Mets Tumor Board, All above faculty; Jae Y. Kim, MD, City of Hope Medical Group; Percy Lee, MD, FASTRO, City of Hope National Medical Center/Orange County and Coastal Radiation Oncology
|
Neuroendocrine and NET Tumor Board
Moderators: Nicholas Fidelman, MD, University of California San Francisco; Michael Soulen, MD, University of Pennsylvania
- Emerging Medical and Surgical Approaches for NET Liver Metastases: 2024 Update, Emily Begsland, MD, UC San Diego
- State-of-the-Art PRRT: Which Patients Should Get PRRT and Which Should Get Emblotherapy? Ghassan El-Haddad, MD, H. Lee Moffitt Cancer Center and Research Institute
- TACE, TAE, TARE: Which Therapy is Indicated? Nicholas Fidelman, MD, University of California San Francisco
- Therapy Selection for Progressive Low Volume Liver and Extrahepatic Disease, Jaydira Del Rivero, MD, National Cancer Institute/National Institutes of Health
- Pre- and Post-Procedure Care in Neuroendocrine Tumors: Practical Tips to Avoid Complications During LRTB, Michael Soulen, MD, University of Pennsylvania
- NET Tumor Board, All above faculty
|
Ablation Hands-on: Image Guidance & Robotics
Moderators: Bruno C. Odisio, MD, PhD, FSIR, The University of MD Anderson Cancer Center; Marie Beerman, MD, Danderyd Hospital
- Rationale Behind Using Image Guidance and Advanced Ablation, Denis Szejnfeld, MD, PhD, Unifesp
- Basics of Stereotactic Ablation and Setting Up a Program, Iwan Paolucci, PhD, MD Anderson Cancer Center
- Stereotactic RF Ablation of the Liver: Why I Use It and the Advantages of Multiple Needles, Reto Bale, MD FCIRSE, Medical University Inssbruck
- Stereotactic Microwave Ablation of Liver Lesions, Marie Beerman, MD, Danderyd Hospital
- Putting it All Together: Treatment Planning, Guidance, and Ablation, Bruno C. Odisio, MD, PhD, FSIR, The University of MD Anderson Cancer Center
- Hands-on Learning, All above faculty
|
2:30 p.m. - 3:30 p.m. |
AI
Moderators: Aaron Abajian, MD; Judy Gichoya Wawira, MS, PhD, Emory University
- AI for Dummies: Everything You're Too Embarrassed to Ask, Joseph Erinjeri, MD, PhD, Memorial Sloan Kettering Cancer Center/Weill Cornell Medical College
- Augmenting IR Imaging with Artificial Intelligence, Jarrel Chen Yi Seah, MBBS, BMedSci(Hons), Harrison.ai/Radiology Registrar at Alfred Health
- Practical and Ethical Challenges with Artificial Intelligence, Judy Gichoya Wawira, MS, PhD, Emory University
- AI in HCC Therapy: Treatment Planning and Response Assessment, Aaron Abajian, MD
|
SIO Grant Showcase
Moderator: Julius Chapiro, MD, PhD, Yale School of Medicine
- SIO Grants Overview, Julius Chapiro, MD, PhD, Yale School of Medicine
- 2022 Grant Update: Single Cell Analysis of Combined Thermal Ablation and Immunotherapy of HCC, Prof. S. Nahum Goldberg, MD, FSIR, FCIRSE, Hadassah Hebrew University Medical Center
- 2022 Grant Update: Stoking an Anti-Liver Cancer Immune Response with Cryoablation Plus Intratumoral Immunostimulant, Isabel Gala Newton, MD, PhD, UCSD Health and VA San Diego Healthcare System
- 2022 Grant Update: Immunobiologic and Metabolic Determinants of Response to Combination Locoregional and Immunotherapy in HCC, Kelley Weinfurtner, MD, University of Pennsylvania
- 2022 Grant Update: Engineered Extracellular Vesicles to Modulate Immunotherapy in Liver Cancer, Kiyoyuki Minamiguchi, MD, PhD, MD Anderson Cancer Center
- 2023 Grant Update, Recipient TBD
- 2023 Grant Update, Recipient TBD
|
Y90 Glass
Moderators: Edward Kim, MD, FSIR, Mount Sinai Health Systems; Riad Salem, MD, MBA, Northwestern University
- Systemic Therapies and Y90, Nora Tabori, MD, Medstar Health
- Why Rad Seg is Curative, Kirema Garcia-Reyes, MD, Icahn School of Medicine at Mount Sinai
- Specific Activity and Does Dose Matter, Christopher D. Malone, MD, Mallinckrodt Institute of Radiology at Washington University School of Medicine
- Why Y90 for PVT is Still Relevant, Robert Lewandowski, MD, FSIR, Northwestern University
- Consolidative Y90 Techniques for Large HCC, Jin Woo Choi, MD, PhD, Seoul National University Hospital
|
3:30 p.m. - 5:00 p.m. |
Expo Hall and Discovery Theatre
Additional details to come.
|
5:00 p.m. - 6:00 p.m. |
HCC Tumor Board
Moderators: Riad Salem, MD, MBA, Northwestern University; Muneeb Ahmed, MD, FSIR, Beth Israel Deaconess Medical Center/Harvard Medical School
Faculty: Roberto Lezzi, MD, FCIRSE; Laura Crocetti, MD, PhD, EBIR, University of Pisa; Parissa Tabrizian, MD, MSc, FACS, Mount Sinai Medical Center; Terrence Williams, MD, City of Hope Medical Group; Adam Burgoyne, MD, PhD, UC San Diego; Sammy Saab, MD, UCLA |
6:00 p.m. - 7:30 p.m. |
Science and Industry Welcome Reception
All attendees are invited to join us to celebrate the start of the 2024 Annual Meeting. This networking reception will include poster and award presentations in the Exhibit Hall.
|